Acalabrutinib

In stock
Note:
All Products are stable to be shipped at room temperature, unless otherwise specified.

Acalabrutinib, is an experimental anti-cancer drug and a selective Bruton's tyrosine kinase (BTK) inhibitor. This kinase transmits signals from B-cell Receptor (BCR), and thus any genetic BTK mutation causes B-Cell immunodeficiency. Therefore, BTK inhibitors targeting B-cell signaling has shown great promise for the treatment of chronic lymphocytic leukemia (CLL).

More Information
SKU RCLST506511
CAS number 1420477-60-6
Molecular Formula C26H23N7O2
Catalog Number RCLST506511
Chemical Name Acalabrutinib
Molecular Weight 465.51
Solubility DMSO (Slightly), Ethanol (Slightly), Methanol (Slightly)
Stability No Data Available
Appearance Light Yellow Solid
Storage Condition Refrigerator